Literature DB >> 3276114

Smoking and mechanisms of cardiovascular control.

D Robertson1, C J Tseng, M Appalsamy.   

Abstract

In humans short-term administration of nicotine, whether by smoking or intravenous injection, will typically raise blood pressure by 5 to 10 mm Hg and heart rate by 10 to 25 bpm. Smoking causes reduced myocardial contractility and left ventricular function in patients with angina pectoris or heart failure. Nicotine's mechanism of action is more complex than the classic concept of nicotinic ganglionic stimulation can account for. Nicotine exerts a potent pressor effect in the ventral lateral medulla (C-1 area). Little current data are available documenting the efficacy of centrally acting antihypertensive agents and converting-enzyme inhibitors with regard to preventing nicotine's acute cardiovascular effects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3276114     DOI: 10.1016/0002-8703(88)90646-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  13 in total

1.  Effects of celiprolol on cardiovascular responses to smoking in normotensive smokers.

Authors:  R Fogari; G D Malamani; A Zoppi; P Lazzari; F Tettamanti; A Mugellini; L Corradi
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

2.  Association between smoking status and cardiovascular and cortisol stress responsivity in healthy young men.

Authors:  M P Roy; A Steptoe; C Kirschbaum
Journal:  Int J Behav Med       Date:  1994

3.  Effects of cigarette smoking on heart rate variability and plasma N-terminal pro-B-type natriuretic peptide in healthy subjects: is there the relationship between both markers?

Authors:  Omer Alyan; Fehmi Kacmaz; Ozcan Ozdemir; Orhan Maden; Serkan Topaloglu; Cemal Ozbakir; Fatma Metin; Aziz Karadede; Erdogan Ilkay
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-04       Impact factor: 1.468

4.  Changes in muscle blood flow after smoking a cigarette determined by a new noninvasive method.

Authors:  F Weber; M Anlauf; R D Müller
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Peripheral haemodynamic effects of smoking in habitual smokers. A methodological study.

Authors:  I Berlin; A Cournot; P Renout; J Duchier; M Safar
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  AAV-directed persistent expression of a gene encoding anti-nicotine antibody for smoking cessation.

Authors:  Martin J Hicks; Jonathan B Rosenberg; Bishnu P De; Odelya E Pagovich; Colin N Young; Jian-ping Qiu; Stephen M Kaminsky; Neil R Hackett; Stefan Worgall; Kim D Janda; Robin L Davisson; Ronald G Crystal
Journal:  Sci Transl Med       Date:  2012-06-27       Impact factor: 17.956

7.  Dual effect of nicotine on cardiac noradrenaline release during metabolic blockade.

Authors:  G Richardt; T Brenn; M Seyfarth; M Haass; E Schömig; A Schömig
Journal:  Basic Res Cardiol       Date:  1994 Nov-Dec       Impact factor: 17.165

8.  Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats.

Authors:  Emily M Jutkiewicz; Kenner C Rice; F Ivy Carroll; James H Woods
Journal:  Drug Alcohol Depend       Date:  2013-01-18       Impact factor: 4.492

9.  Tobacco and myocardial infarction: is snuff less dangerous than cigarettes?

Authors:  F Huhtasaari; K Asplund; V Lundberg; B Stegmayr; P O Wester
Journal:  BMJ       Date:  1992-11-21

10.  Haemodynamic responses to tobacco smoke inhalation in male adolescents in Lusaka, Zambia.

Authors:  Theresa Chikopela; Fastone M Goma
Journal:  Cardiol Angiol       Date:  2015-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.